Failure of Helicobacter pylori eradication and age are independent risk factors for recurrent neoplasia after endoscopic resection of early gastric cancer in 283 patients

Alimentary Pharmacology and Therapeutics

Volumn 39, Issue 6, 2014, Pages 609-618

  Kwon, Y H ^a   Heo, J ^a   Lee, H S ^a   Cho, C M ^a   Jeon, S W ^a  

^a Kyungpook National University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE; OMEPRAZOLE; RABEPRAZOLE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER RECURRENCE; CONTROLLED STUDY; DRUG TREATMENT FAILURE; EARLY CANCER; ENDOSCOPIC SUBMUCOSAL DISSECTION; ERADICATION THERAPY; FEMALE; FOLLOW UP; HAZARD RATIO; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INDEPENDENT VARIABLE; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; METACHRONOUS STOMACH LESION; MORBIDITY; PATHOGENESIS; PERSISTENT INFECTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; STOMACH CANCER; STOMACH LESION; THERAPY EFFECT; TREATMENT OUTCOME;

AGE FACTORS; AGED; DISSECTION; FEMALE; FOLLOW-UP STUDIES; GASTRIC MUCOSA; GASTROSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; STOMACH NEOPLASMS;

EID: 84894529160     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12633     Document Type: Article

References (36)

1. Parsonnet J, Friedman GD, Vandersteen DP, et al,. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325: 1127-31.
2. International Agency for Research on Cancer. World Health Organization Schistosomes, liver flukes and Helicobacter pylori. IARC Monogr Eval Carcinog Risks Hum 1994; 61: 177-241.
3. Huang J-Q, Sridhar S, Chen Y, Hunt RH,. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 1998; 114: 1169-79.
4. Maruta F, Sugiyama A, Ishizone S, Miyagawa S, Ota H, Katsuyama T,. Eradication of Helicobacter pylori decreases mucosal alterations linked to gastric carcinogenesis in Mongolian gerbils. J Gastroenterol 2005; 40: 104-5.
5. Nakagawa S, Asaka M, Kato M, et al,. Helicobacter pylori eradication and metachronous gastric cancer after endoscopic mucosal resection of early gastric cancer. Aliment Pharmacol Ther 2006; 24 (s4): 214-8.
6. Fukase K, Kato M, Kikuchi S, et al,. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. The Lancet 2008; 372: 392-7.
7. Maehata Y, Nakamura S, Fujisawa K, et al,. Long-term effect of Helicobacter pylori eradication on the development of metachronous gastric cancer after endoscopic resection of early gastric cancer. Gastrointest Endosc 2012; 75: 39-46.
8. Correa P,. A human model of gastric carcinogenesis. Cancer Res 1988; 48: 3554-60.
9. Chon I, Choi C, Shin CM, Park YS, Kim N, Lee DH,. Effect of Helicobacter pylori eradication on subsequent dysplasia development after endoscopic resection of gastric dysplasia. Korean J Gastroenterol 2013; 61: 307-12.
10. Kawaramachi K-k, Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer 2011; 14: 101-12.
11. Stolte M,. The new Vienna classification of epithelial neoplasia of the gastrointestinal tract: advantages and disadvantages. Virchows Arch 2003; 442: 99-106.
12. Kimura K, Takemoto T,. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy 1969; 1: 87-97.
13. Manfred Stolte M,. The updated Sydney system: classification and grading of gastritis as the basis of diagnosis and treatment. Can J Gastroenterol 2001; 15: 591.
14. Uemura N, Mukai T, Okamoto S, et al,. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomark Prev 1997; 6: 639-42.
15. Takeda J, Toyonaga A, Koufuji K, et al,. Early gastric cancer in the remnant stomach. Hepatogastroenterology 1998; 45: 1907-11.
16. Nicholls JC,. Stump cancer following gastric surgery. World J Surg 1979; 3: 731-4.
17. Nasu J, Doi T, Endo H, Nishina T, Hirasaki S, Hyodo I,. Characteristics of metachronous multiple early gastric cancers after endoscopic mucosal resection. Endoscopy 2005; 37: 990-3.
18. Nakajima T, Oda I, Gotoda T, et al,. Metachronous gastric cancers after endoscopic resection: how effective is annual endoscopic surveillance? Gastric Cancer 2006; 9: 93-8.
19. Hansson L-E, Nyrén O, Hsing AW, et al,. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med 1996; 335: 242-9.
20. Uemura N, Okamoto S, Yamamoto S, et al,. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 784-9.
21. Hojo M, Miwa H, Ohkusa T, Ohkura R, Kurosawa A, Sato N,. Alteration of histological gastritis after cure of Helicobacter pylori infection. Aliment Pharmacol Ther 2002; 16: 1923-32.
22. Correa P, Fontham ET, Bravo JC, et al,. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy. J Natl Cancer Inst 2000; 92: 1881-8.
23. Ley C, Mohar A, Guarner J, et al,. Helicobacter pylori eradication and gastric preneoplastic conditions a randomized, double-blind, placebo-controlled trial. Cancer Epidemiol Biomark Prev 2004; 13: 4-10.
24. Wong BC-Y, Lam SK, Wong WM, et al,. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China. JAMA 2004; 291: 187-94.
25. Wu C, Kuo K, Wu M, Chen Y, Wang C, Lin J,. Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease. Eur J Gastroenterol Hepatol 2010; 22: 125-8.
26. Asaka M, Kato MY, Graham D,. Prevention of gastric cancer by Helicobacter pylori eradication. Intern Med 2010; 49: 633-6.
27. Kobayashi D, Takahashi O, Arioka H, Fukui T,. The optimal screening interval for gastric cancer using esophago-gastro-duodenoscopy in Japan. BMC gastroenterology 2012; 12: 144.
28. Anderson WF, Camargo MC, Fraumeni JF Jr, Correa P, Rosenberg PS, Rabkin CS,. Age-specific trends in incidence of noncardia gastric cancer in US adults. JAMA 2010; 303: 1723-8.
29. Asaka M, Kato M, Graham DY,. Strategy for eliminating gastric cancer in Japan. Helicobacter 2010; 15: 486-90.
30. Kim N, Park RY, Cho S-I, et al,. Helicobacter pylori infection and development of gastric cancer in Korea: long-term follow-up. J Clin Gastroenterol 2008; 42: 448-54.
31. Kushi LH, Byers T, Doyle C, et al,. American Cancer Society Guidelines on Nutrition and Physical Activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin 2006; 56: 254-81.
32. Sung JJ, Lin S-R, Ching JY, et al,. Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study. Gastroenterology 2000; 119: 7-14.
33. Leung W, Lin S, Ching J, et al,. Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication. Gut 2004; 53: 1244-9.
34. Rokkas T, Pistiolas D, Sechopoulos P, Robotis I, Margantinis G,. The long-term impact of Helicobacter pylori eradication on gastric histology: a systematic review and meta-analysis. Helicobacter 2007; 12 (s2): 32-8.
35. Fontham E, Ruiz B, Perez A, Hunter F, Correa P,. Determinants of Helicobacter pylori infection and chronic gastritis. Am J gastroenterol 1995; 90: 1094.
36. Rugge M, Cassaro M, Leandro G, et al,. Helicobacter pylori in promotion of gastric carcinogenesis. Dig Dis Sci 1996; 41: 950-5.